Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Annandale, New Jersey 08801


Purpose:

Examine the ability of Timunox (thymopentin) to reduce the amount and/or frequency of virus isolation. Examine the ability of thymopentin to stimulate the immune system and alter the clinical findings in patients infected with HIV who do not yet have AIDS.


Criteria:

Inclusion Criteria Concurrent Medication: Allowed: - Aerosolized pentamidine. Patients must have the following: - Seropositive for HIV-1 (ELISA assay) confirmed by Western blot. - HIV-1 p24 antigen must be detected in supernatant fluids from co-cultures of patients' peripheral blood monocytes (PBMC) on two separate occasions. - Voluntarily sign consent. - Patients with HIV "wasting syndrome" are allowed. Prior Medication: Allowed: - Aerosolized pentamidine. Exclusion Criteria Co-existing Condition: Patients with the following are excluded: - AIDS as defined by the CDC. - Significant hepatic disease. - Thrombocytopenia. - Hypersensitivity to thymopentin. - Hemophilia A or B or other hematologic disorders requiring current or previous administration of blood products. - Abnormal chest x-ray (indicative of active disease (opportunistic infection)) within 30 days prior to study entry. Patients with the following are excluded: - AIDS as defined by the CDC. - Significant hepatic disease. - Thrombocytopenia. - Hypersensitivity to thymopentin. - Hemophilia A or B or other hematologic disorders requiring current or previous administration of blood products. - Abnormal chest x-ray (indicative of active disease (opportunistic infection)) within 30 days prior to study entry. Prior Medication: Excluded within 30 days of study entry: - Immunomodulatory or experimental therapy. - Excluded within 90 days of study entry: - Zidovudine (AZT). Intravenous drug abuse.


NCT ID:

NCT00002289


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Annandale, New Jersey 08801
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.